Ignite Creation Date:
2025-12-24 @ 2:07 PM
Ignite Modification Date:
2026-02-03 @ 3:52 AM
Study NCT ID:
NCT06081595
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-10-13
First Post:
2023-10-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fluzoparib Combined With Apatinib in Relapsed Ovarian Carcinoma Maintenance Treatment
Sponsor:
Jin Li
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MA-OC-II-011
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None